What are we looking for?
We are seeking innovative ideas that can serve as cornerstones for fresh biopharmaceutical companies. We evaluate early-stage projects, in all therapeutic areas and modalities, from target ID to lead optimization phase in the drug discovery process.
Since the goal of EXTEND is to create new companies from academic research, we favor projects that are not yet been incorporated into a company. Nevertheless, we will be keen to evaluate submissions from formed start-ups and assess their potential.
Don’t worry if you are a Post Doc or a Professor with a promising discovery but lacking resources. We will be happy to assemble the team in these cases!
Please, contact the Expert in Residence (EIR) even if you do not believe your project is ready to apply yet. Initial interaction and discussion with him might provide different perspectives to get your project ready to start.
Having received initial funding for your discovery project, it does not preclude you from applying, unless you are approaching the clinical phase.